Edgewell Personal Care (EPC) 10-Q 10 Feb 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Dec. 31, 2019	Jan. 31, 2020
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2019
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		54,303,438
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net sales	$ 454	$ 457.1
Cost of products sold	260.9	263.6
Gross profit	193.1	193.5
Selling, general and administrative expense	95	87.3
Advertising and sales promotion expense	41.1	51.6
Research and development expense	13.8	12.6
Restructuring charges	6.1	17.1
Gain on sale of Infant and Pet Care business	(5.2)	0
Interest expense associated with debt	14.3	16
Other (income) expense, net	(1.6)	1.3
Earnings before income taxes	29.6	7.6
Income tax provision	7.2	8
Net earnings (loss)	$ 22.4	$ (0.4)
Basic net earnings (loss) per share	$ 0.41	$ (0.01)
Diluted net earnings (loss) per share	$ 0.41	$ (0.01)
Condensed Consolidated Statements of Comprehensive Income
Net earnings (loss)	$ 22.4	$ (0.4)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	21.5	(10.8)
Pension and postretirement activity, net of tax	(1.5)	0
Deferred (loss) gain on hedging activity, net of tax	(1.3)	(1.3)
Total other comprehensive income (loss), net of tax	18.7	(12.1)
Total comprehensive income (loss)	$ 41.1	$ (12.5)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Pension and postretirement activity, tax	$ (0.6)	$ 0.1
Deferred (loss) gain on hedging activity, tax	$ (0.6)	$ (0.7)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2019	Sep. 30, 2019
Current assets
Cash and cash equivalents	$ 251.8	$ 341.6
Trade receivables, less allowance for doubtful accounts	183.2	205.6
Inventories	367	357.2
Other current assets	144.6	140
Total current assets	946.6	1,044.4
Property, plant and equipment, net	384.8	396
Goodwill	1,030.8	1,032.8
Other intangible assets, net	843.7	912.9
Other assets	97.3	34.8
Total assets	3,303.2	3,420.9
Current liabilities
Current maturities of long-term debt	0	117
Notes payable	17	14.4
Accounts payable	195.1	222.8
Other current liabilities	250.4	305.4
Total current liabilities	462.5	659.6
Long-term debt	1,098.1	1,097.8
Deferred income tax liabilities	84	101.1
Other liabilities	310.5	258.9
Total liabilities	1,955.1	2,117.4
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,622.7	1,627.7
Retained earnings	737.2	714.8
Common shares in treasury at cost	(795.3)	(803.8)
Accumulated other comprehensive loss	(217.2)	(235.9)
Total shareholders’ equity	1,348.1	1,303.5
Total liabilities and shareholders’ equity	$ 3,303.2	$ 3,420.9

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2019	Sep. 30, 2019
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 4.7	$ 5.6
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	54,300,084	54,206,746
Treasury shares (in shares)	10,951,905	11,045,243

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flow from Operating Activities
Net earnings (loss)	$ 22.4	$ (0.4)
Depreciation and amortization	22.5	22.1
Share-based compensation expense	4.9	4.9
Loss on sale of assets	0.2	0.7
Gain on sale of Infant and Pet Care business	(5.2)	0
Deferred compensation payments	(1.9)	(0.3)
Deferred income taxes	(16.7)	(0.1)
Other, net	5.4	5.4
Change in operating assets and liabilities	(78.5)	(78.7)
Net cash used by operating activities	(46.9)	(46.4)
Cash Flow from Investing Activities
Capital expenditures	(7.6)	(9.4)
Proceeds from sale of Infant and Pet Care business	95.8	0
Proceeds from sale of assets	0	4
Collection of deferred purchase price on accounts receivable sold	2.8	2.5
Payments for other investing activities	(1.3)	0
Net cash from (used by) from investing activities	89.7	(2.9)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	50	137
Cash payments on debt with original maturities greater than 90 days	(167)	(105)
Net decrease in debt with original maturities of 90 days or less	(0.1)	(0.9)
Net financing outflow from the Accounts Receivable Facility	(14.9)	(5.1)
Employee shares withheld for taxes	(1.5)	(1.5)
Payments for other financing activities	(2.4)	0
Net cash (used by) from financing activities	(135.9)	24.5
Effect of exchange rate changes on cash	3.3	(1.7)
Net decrease in cash and cash equivalents	(89.8)	(26.5)
Cash and cash equivalents, beginning of period	341.6	266.4
Cash and cash equivalents, end of period	$ 251.8	$ 239.9

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Common shares	Treasury shares	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(11,200,000)
Common shares, issued (in shares)		65,200,000
Total shareholders' equity at Sep. 30, 2018	$ 1,744.6	$ 0.7	$ (819.2)	$ 1,628.3	$ 1,083.1	$ (148.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	(0.4)				(0.4)
Foreign currency translation adjustments	(10.8)					(10.8)
Pension and postretirement activity, net of tax	0					0
Deferred (loss) gain on hedging activity, net of tax	(1.3)					(1.3)
Impact of ASU 2016-16	3.9				3.9
Activity under share plans (in shares)			100,000
Activity under share plans (in usd)	3.3		$ 6.6	3.3	0
Total shareholders' equity at Dec. 31, 2018	$ 1,739.3	$ 0.7	$ (812.6)	1,625	1,086.6	(160.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(11,100,000)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)	11,045,243		(11,000,000)
Common shares, issued (in shares)	65,251,989	65,200,000
Total shareholders' equity at Sep. 30, 2019	$ 1,303.5	$ 0.7	$ (803.8)	1,627.7	714.8	(235.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	22.4				22.4
Foreign currency translation adjustments	21.5					21.5
Pension and postretirement activity, net of tax	(1.5)					(1.5)
Deferred (loss) gain on hedging activity, net of tax	(1.3)					(1.3)
Activity under share plans (in shares)			100,000
Activity under share plans (in usd)	3.5		$ 8.5	5	0
Total shareholders' equity at Dec. 31, 2019	$ 1,348.1	$ 0.7	$ (795.3)	$ 1,622.7	$ 737.2	$ (217.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)	10,951,905		(10,900,000)
Common shares, issued (in shares)	65,251,989	65,200,000

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company, and its subsidiaries (collectively, “Edgewell” or the “Company”), is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. Edgewell operates in more than 20 countries with extensive retail reach across 50 markets. The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Shave Guard® and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black® and Bulldog® men’s skin care products, and Wet Ones® wipes. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. • Through December 2019, the Company also conducted business in its All Other segment which included infant care products, such as bottles, cups, and pacifiers, sold under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. The Company completed the sale of the infant and pet care business in December 2019. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”), under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 26, 2019. Recently Adopted Accounting Pronouncements. In February 2016, the Financial Account Standards Board (“FASB”) issued ASU 2016-02, which amends existing lease accounting guidance to require recognition of lease assets and lease liabilities on the balance sheet for leases previously classified as operating leases. Additionally, this update requires qualitative disclosure along with specific quantitative disclosures. The Company adopted the standard October 1, 2019, using the modified retrospective approach with no restatement of prior period amounts. As a result of adoption, the Company recognized leased right of use assets and liabilities of $57.4 and $57.5, respectively. The impact to the Consolidated Statement of Earnings and Consolidated Statement of Cash Flows was not material for the first quarter of fiscal 2020. Refer to Note 8 in the Notes to the Condensed Consolidated Financial Statements for further discussion. In August 2017, the FASB issued ASU 2017-12, which eliminates the requirement to separately measure and report hedge ineffectiveness and generally requires, for qualifying hedges, the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. The guidance also modifies the accounting for components excluded from the assessment of hedge effectiveness, eases documentation and assessment requirements and modifies certain disclosure requirements. The Company adopted the standard effective October 1, 2019. The impact from adoption of this new accounting pronouncement was not material to the Company's financial statements for the first quarter of fiscal 2020. In June 2018, the FASB issued ASU 2018-07, which simplifies the treatment of share-based payment transactions used in acquiring goods and services from non-employees. The amendments note that measurement of share-based payments used to acquire goods or services should be valued at the grant-date fair value. The grant date is defined as the date at which the grantor and grantee reach a mutual understanding of the terms and conditions of the award. Finally, any awards containing a performance condition should be valued considering the probability of satisfying the necessary performance conditions consistent with employee share-based awards. The Company adopted the ASU effective October 1, 2019. The impact from adopting this guidance was not material to the Company's financial statements for the first quarter of fiscal 2020. Recently Issued Accounting Pronouncements. In June 2016, the FASB issued ASU 2016-13 intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The new guidance applies to all financial instruments, including trade receivables, and requires the measurement of all expected credit losses for financial assets held at a reporting date to be based on historical experience, current conditions and reasonable and supportable forecasts. Previous guidance did not include forward-looking information. The update will be effective for the Company beginning October 1, 2020 and early adoption is permitted for fiscal years beginning after December 15, 2018. The Company is in the process of evaluating the impact the guidance will have on its financial statements. The impact of the new guidance is not expected to be material and will be dependent on the credit quality of the trade receivables outstanding at the date of adoption. The Company evaluates the credit-worthiness of customers when negotiating contracts and, as trade receivables are short term in nature, the timing between recognition of a credit loss under existing guidance and the new guidance is not expected to differ materially. In August 2018, the FASB issued ASU 2018-13 adjusting the disclosure requirements for fair value measurements. The guidance updates the disclosure requirements regarding leveling of fair value assets and the valuation of Level 3 fair value measurements. The update will be effective for the Company beginning October 1, 2020 and early adoption is permitted. The Company is in the process of evaluating the impact the guidance will have on its financial statements. In August 2018, the FASB issued ASU 2018-14, which modifies the disclosure requirements for defined benefit pension plans and other post retirement plans. The guidance removes disclosures that are no longer considered cost beneficial, clarifies the specific requirements of disclosures and adds disclosure requirements identified as relevant. The new standard will be effective for the Company beginning October 1, 2020 and early adoption is permitted. The Company is in the process of evaluating the impact of this guidance but does not expect it to result in a material change to the financial statements. In August 2018, the FASB issued ASU 2018-15, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments in this ASU require an entity that is the customer in a hosting arrangement to follow the guidance on internal-use software to determine which implementation costs to capitalize and which costs to expense. The standard also requires a customer to expense the capitalized implementation costs of a hosting arrangement over the term of the hosting arrangement. The new guidance requires an entity to present the expense related to the capitalized implementation costs in the same line item in the statement of income as the fees associated with the hosting element of the arrangement and classify payments for capitalized implementation costs in the statement of cash flows in the same manner as payments made for fees associated with the hosting element. The entity is also required to present the capitalized implementation costs in the statement of financial position in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented. The guidance is effective for the Company beginning October 1, 2020 and early adoption is permitted. The Company is in the process of evaluating the impact of this guidance will have on its financial statements. In December 2019, the FASB issued ASU 2019-12, which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period when interim loss exceeds anticipated loss for the year, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for the Company beginning October 1, 2021, with early adoption permitted. The Company is in the process of evaluating the impact this guidance will have on its financial statements.

Divestitures

Divestitures	3 Months Ended
	Dec. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Disposal group	Divestitures Sale of Infant and Pet Care Business On December 17, 2019, the Company completed the sale of its Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. The Company received proceeds of $107.5 including support for the transition services agreement, and the remaining sales price receivable includes $7.5 reported in current assets and $5.0 reported in other assets as of December 31, 2019. Total assets included in the sale were comprised of $19.5 of inventory, $3.2 of property, plant and equipment, and $77.8 of goodwill and intangible assets. The sale of the Infant and Pet Care business resulted in a gain of $5.2, net of expenses incurred to facilitate the closing of the transaction and in support of the transition services agreement.

Restructuring Charges

Restructuring Charges	3 Months Ended
	Dec. 31, 2019
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Project Fuel In February 2018, the Company announced Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of the Company’s business and cost structure, simplifying and transforming the organization, structure, and key processes that will enable the Company to achieve its desired future state operations. The Company has incurred costs and realized savings for Project Fuel beginning in fiscal 2018 through the first quarter of fiscal 2020 and expects to incur additional costs and realize additional savings through fiscal 2021. The Company does not include Project Fuel restructuring costs in the results of its reportable segments. The estimated impact of allocating such charges to segment results for fiscal 2020 would have been as follows: Three Months Ended December 31, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ — $ — $ — $ — $ 1.3 1.3 Asset impairment and accelerated depreciation — — — — — — Consulting, project implementation and management, and other exit costs 2.8 — — — 3.9 6.7 Total Restructuring $ 2.8 $ — $ — $ — $ 5.2 $ 8.0 Three Months Ended December 31, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 7.3 $ 0.5 $ 0.3 $ 0.1 $ 1.0 $ 9.2 Asset impairment and accelerated depreciation — — — — 0.5 0.5 Consulting, project implementation and management, and other exit costs 2.3 — — — 6.5 8.8 Total Restructuring $ 9.6 $ 0.5 $ 0.3 $ 0.1 $ 8.0 $ 18.5 Pre-tax Selling, General and Administrative expense (“SG&A”) of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses related to Project Fuel were included in Consulting, project implementation and management, and other exit costs. The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2020: Utilized October 1, 2019 Charge to Other (1) Cash Non-Cash December 31, Restructuring Severance and related benefit costs $ 8.2 $ 1.3 $ — $ (2.6) $ — $ 6.9 Asset impairment and accelerated depreciation — — — — — — Consulting, project implementation and management, and other exit costs 1.3 6.7 — (6.4) — 1.6 Total Restructuring $ 9.5 $ 8.0 $ — $ (9.0) $ — $ 8.5 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended December 31, 2019, the Company had income tax expense of $7.2 on Earnings before income taxes of $29.6. The effective tax rate for the three months ended December 31, 2019 was 24.4%. The difference between the federal statutory rate and the effective rate is primarily due to the unfavorable impact of the Infant and Pet Care sale. For the three months ended December 31, 2018, the Company had income tax expense of $8.0 on Earnings before income taxes of $7.6. The effective tax rate for the three months ended December 31, 2018 was 105.7%. The difference between the federal statutory rate and the effective rate is primarily due to a $4.7 net transitional charge related to the Tax Cuts and Jobs Act. The rate was also unfavorably impacted by $18.5 of restructuring and other related costs in lower tax rate jurisdictions and unfavorable tax adjustments, including the impact of the share-based payment guidance.

Earnings per Share

Earnings per Share	3 Months Ended
	Dec. 31, 2019
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent (“RSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended 2019 2018 Basic weighted-average shares outstanding 54.3 54.1 Effect of dilutive securities: RSE awards 0.1 — Total dilutive securities 0.1 — Diluted weighted-average shares outstanding 54.4 54.1 For the three months ended December 31, 2019, the calculation of diluted weighted-average shares outstanding excludes 0.7 of share options and 0.1 of RSE awards because the effect of including these awards was anti-dilutive. For the three months ended December 31, 2018, the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options and 0.2 of RSE awards because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Gross balance at October 1, 2019 $ 960.3 $ 228.3 $ 207.0 $ 69.6 $ 1,465.2 Accumulated goodwill impairment (369.0) (2.0) — (61.4) (432.4) Net balance at October 1, 2019 $ 591.3 $ 226.3 $ 207.0 $ 8.2 $ 1,032.8 Changes in the three-month period ended December 31, 2019 Infant and Pet Care divestiture — — — (8.2) (8.2) Cumulative translation adjustment 4.2 1.2 0.8 — 6.2 Gross balance at December 31, 2019 $ 964.5 $ 229.5 $ 207.8 $ 61.4 $ 1,463.2 Accumulated goodwill impairment (369.0) (2.0) — (61.4) (432.4) Net balance at December 31, 2019 $ 595.5 $ 227.5 $ 207.8 $ — $ 1,030.8 December 31, 2019 September 30, 2019 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.5 $ 37.6 $ 168.9 $ 206.4 $ 35.0 $ 171.4 Technology and patents 76.2 74.5 1.7 78.5 76.4 2.1 Customer related and other 178.4 103.4 75.0 176.0 100.9 75.1 Total amortizable intangible assets $ 461.1 $ 215.5 $ 245.6 $ 460.9 $ 212.3 $ 248.6 Amortization expense was $4.3 and $4.5 for the three months ended December 31, 2019 and 2018, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2020 and for fiscal 2021, 2022, 2023, 2024, and 2025 is $12.7, $16.5, $16.4, $16.4, $16.3, and $16.3, respectively, and $151.0 thereafter. The Company had indefinite-lived intangible assets of $598.2 ($179.7 in Wet Shave, $388.6 in Sun and Skin Care, $29.9 in Feminine Care, and $0.0 in All Other) at December 31, 2019, a decrease of $66.1 from September 30, 2019, which was the result of the sale of the Diaper Genie indefinite lived intangible asset. The Company had indefinite-lived trade names and brands of $664.3 ($177.7 in Wet Shave, $387.9 in Sun and Skin Care, $29.9 in Feminine Care, and $68.8 in All Other) at September 30, 2019. Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment of value or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. The Company continuously monitors events which could trigger an interim impairment analysis, such as changing business conditions and environmental factors. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. Refer to the sensitivity analysis in Management's Discussion and Analysis in the Company’s Annual Report on Form 10-K filed with the SEC on November 26, 2019.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
	Dec. 31, 2019
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information December 31, September 30, Inventories Raw materials and supplies $ 58.9 $ 55.1 Work in process 63.0 66.5 Finished products 245.1 235.6 Total inventories $ 367.0 $ 357.2 Other Current Assets Miscellaneous receivables $ 23.0 $ 14.9 Inventory returns receivable 0.6 4.9 Prepaid expenses 68.1 65.0 Value added tax collectible from customers 19.7 23.0 Income taxes receivable 16.0 29.1 Other 17.2 3.1 Total other current assets $ 144.6 $ 140.0 Property, Plant and Equipment Land $ 18.9 $ 18.7 Buildings 137.5 137.4 Machinery and equipment 991.8 992.3 Capitalized software costs 46.3 47.8 Construction in progress 40.4 40.9 Total gross property, plant and equipment 1,234.9 1,237.1 Accumulated depreciation and amortization (850.1) (841.1) Total property, plant and equipment, net $ 384.8 $ 396.0 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 41.7 $ 51.9 Accrued trade allowances 23.4 26.2 Accrued salaries, vacations and incentive compensation 34.7 51.5 Income taxes payable 19.6 11.5 Returns reserve 27.0 60.4 Restructuring reserve 8.5 9.5 Value added tax payable 3.0 3.6 Deferred compensation 6.4 10.4 Short term lease obligation 12.0 — Customer advance payments 1.5 1.7 Other 72.6 78.7 Total other current liabilities $ 250.4 $ 305.4 Other Liabilities Pensions and other retirement benefits $ 149.1 $ 149.8 Deferred compensation 33.7 30.3 Long term lease obligation 43.6 — Other non-current liabilities 84.1 78.8 Total other liabilities $ 310.5 $ 258.9

Leases

Leases	3 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Lessee, Operating Leases	Leases The Company adopted ASU 2016-02 on October 1, 2019. The Company has elected to utilize the package of practical expedients permitted under the transition guidance, which allows it to carryforward its historical lease classification, its assessment on whether a contract was or contains a lease, and its assessment of initial direct costs for any leases that existed prior to October 1, 2019. Additionally, the Company has elected an accounting policy not to separate non-lease components from lease components and instead, account for these components as a single lease component. The Company has made an accounting policy election not to recognize ROU assets and lease liabilities for leases that, at the commencement date, are for 12 months or less. For leases that do not provide an implicit rate, the Company uses its secured incremental borrowing rate, based on the information available for leases, including the lease term and interest rate environment in the country in which the lease exists, to calculate the present value of the future lease payments. A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment over a contracted period in exchange for payment. The Company evaluates if an arrangement is a lease at the inception date for the agreement. For operating leases entered into prior to October 1, 2019, the right of use (“ROU”) assets and operating lease liabilities are recognized in the balance sheet based on the present value of the remaining future minimum payments over the lease term from the implementation date. Certain leases include an option to either renew or terminate the lease. For purposes of calculating lease liabilities, these options are included within the lease term when it has become reasonably certain that the Company will exercise such options. Leases entered into subsequent to the implementation date calculate the operating lease ROU asset and operating lease liabilities based on the present value of minimum payments over the lease term at the commencement date of the lease. The Company leases certain offices and manufacturing facilities, warehouses, employee vehicles, and certain manufacturing related equipment. Leases with an initial term of 12 months or less are not recorded on the Condensed Consolidated Balance Sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. A summary of the company's lease information is as follows: Classification December 31, Assets Right of use assets Other assets $ 55.7 Liabilities Current lease liabilities Other current liabilities $ 12.0 Long-term lease liabilities Other liabilities 43.6 Total lease liabilities $ 55.6 Other information Weighted-average remaining lease term (years) 11 Weighted-average incremental borrowing rate 7.0 % Three Months Ended December 31, 2019 Statement of Income Lease cost (1) $ 3.7 Other information Leased assets obtained in exchange for new lease liabilities $ 0.1 Cash paid for amounts included in the measurement of lease liabilities $ 3.8 (1) Lease expense is included in cost of products sold or SG&A expenses based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material. The Company's minimum annual rentals including reasonable assured renewal options under lease agreements are as follows: Operating 2020 $ 10.7 2021 10.7 2022 8.1 2023 6.7 2024 5.3 2025 and thereafter 42.4 Total future minimum lease commitments 83.9 Less: Imputed Interest (28.3) Present value of lease liabilities $ 55.6 At September 30, 2019, the aggregate future minimum rental commitments under all non-cancelable operating lease agreements were as follows: Operating Leases 2020 $ 13.6 2021 10.5 2022 7.4 2023 5.9 2024 4.6 2025 and thereafter 12.5 Total future minimum lease commitments 54.5

Accounts Receivable Facility

Accounts Receivable Facility	3 Months Ended
	Dec. 31, 2019
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facility On September 15, 2017, the Company entered into a $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”). Transfers under this Agreement are accounted for as sales of receivables, resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under the agreement is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company continues to have collection and servicing responsibilities for the receivables sold and receives separate compensation for their servicing. The compensation received is considered acceptable servicing compensation and, as such, the Company does not recognize a servicing asset or liability. As of December 31, 2019, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor.

Debt

Debt	3 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021 $ 600.0 $ 600.0 Senior notes, fixed interest rate of 4.7%, due 2022 500.0 500.0 U.S. revolving credit facility due 2020 — 117.0 Total long-term debt, including current maturities 1,100.0 1,217.0 Less current portion — 117.0 Less unamortized debt issuance costs and discount (1) (2) 1.9 2.2 Total long-term debt $ 1,098.1 $ 1,097.8 (1) At December 31, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.6 and $1.0, respectively. At September 30, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.8 and $1.0, respectively. (2) At December 31, 2019 and September 30, 2019, the balance for the senior notes due 2022 was reflected net of discount of $0.3 and $0.4, respectively.

Retirement Plans

Retirement Plans	3 Months Ended
	Dec. 31, 2019
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement cost for these plans was as follows: Three Months Ended 2019 2018 Service cost $ 1.1 $ 0.7 Interest cost 3.4 4.7 Expected return on plan assets (5.8) (6.3) Recognized net actuarial loss 2.3 1.0 Settlement loss recognized 0.2 — Net periodic cost $ 1.2 $ 0.1 The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings. The remaining net periodic cost is recorded to Other (income) expense, net on the Condensed Consolidated Statement of Earnings.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive (Loss) Income The following table presents the changes in accumulated other comprehensive (loss) income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2019 $ (77.3) $ (159.8) $ 1.2 $ (235.9) OCI before reclassifications (1) 21.5 (3.3) (0.7) 17.5 Reclassifications to earnings — 1.8 (0.6) 1.2 Balance at December 31, 2019 $ (55.8) $ (161.3) $ (0.1) $ (217.2) Foreign Pension and Hedging Total Balance at October 1, 2018 $ (40.6) $ (110.3) $ 2.6 $ (148.3) OCI before reclassifications (1) (10.8) (0.7) (0.1) (11.6) Reclassifications to earnings — 0.7 (1.2) (0.5) Balance at December 31, 2018 $ (51.4) $ (110.3) $ 1.3 $ (160.4) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: For the Three Months Ended Affected Line Item in the Details of AOCI Components 2019 2018 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 0.9 $ 1.8 Other (income) expense, net 0.9 1.8 Total before tax 0.3 0.6 Income tax provision 0.6 1.2 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses $ (2.3) $ (1.0) (1) Settlements (0.2) — (2.5) (1.0) Total before tax (0.7) (0.3) Income tax provision (1.8) (0.7) Net of tax Total reclassifications for the period $ (1.2) $ 0.5 Net of tax (1) These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	3 Months Ended
	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the course of business, the Company enters into contractual arrangements (also referred to as derivatives), to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at December 31, 2019 and September 30, 2019, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other (income) expense, net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At December 31, 2019, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax loss of $0.1 and an unrealized pre-tax gain of $1.7 at December 31, 2019 and September 30, 2019, respectively, on these forward currency contracts, which are accounted for as cash flow hedges, and are included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2019 levels over the next 12 months, most of the pre-tax gain included in AOCI at December 31, 2019 is expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal 2020. At December 31, 2019, there were 61 open foreign currency contracts with a total notional value of $125.0. Derivatives not Designated as Hedges The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and thus are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2019 resulted in a gain of $0.3, compared to a loss of $1.3 for the three months ended December 31, 2018, and was recorded in Other (income) expense, net in the Condensed Consolidated Statements of Earnings. At December 31, 2019, there were five open foreign currency derivative contracts not designated as cash flow hedges, with a total notional value of $39.0. The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) December 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (0.1) $ 1.7 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.2 $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended December 31, 2019 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Loss recognized in OCI (1) $ (0.9) $ (0.2) Gain reclassified from AOCI into income (effective portion) (1) (2) 0.9 1.8 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 0.3 $ (1.3) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. (2) Gain (loss) was recorded in Other (income) expense, net. The following table provides financial assets and liabilities for balance sheet offsetting: At December 31, 2019 At September 30, 2019 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 1.0 $ (0.7) $ 2.4 $ (0.5) Gross amounts offset in the balance sheet (0.2) — — 0.2 Net amounts of assets (liabilities) presented in the balance sheet $ 0.8 $ (0.7) $ 2.4 $ (0.3) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: December 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (40.1) $ (40.6) Derivatives - foreign currency contracts 0.1 2.1 Net liabilities at estimated fair value $ (40.0) $ (38.5) At December 31, 2019, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. At December 31, 2019 and September 30, 2019, the Company had no Level 1 or Level 3 financial assets or liabilities, other than pension plan assets. At December 31, 2019 and September 30, 2019, the fair market value of fixed rate long-term debt was $1,095.6 and $1,071.2, respectively, compared to its carrying value of $1,100.0. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on Level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company’s revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings, and the revolving credit agreements have been determined based on Level 2 inputs.

Segment Data

Segment Data	3 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 to Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, restructuring charges, and certain costs deemed non-recurring in nature, including: acquisition and integration planning costs, the gain on the disposal of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management’s view on how it evaluates segment performance. The Company completed the sale of its Infant and Pet Care business in December 2019. As a result, no additional Net Sales or Segment Profit will be reported for the All Other segment in subsequent periods. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Such allocations are estimates and do not represent the costs of such services if performed on a stand-alone basis. Segment net sales and profitability are presented below: Three Months Ended 2019 2018 Net Sales Wet Shave $ 277.0 $ 287.7 Sun and Skin Care 75.1 66.7 Feminine Care 75.1 74.7 All Other 26.8 28.0 Total net sales $ 454.0 $ 457.1 Segment Profit Wet Shave $ 52.9 $ 55.0 Sun and Skin Care 0.1 (0.6) Feminine Care 13.1 7.5 All Other 3.1 1.2 Total segment profit 69.2 63.1 General corporate and other expenses (13.3) (13.7) Restructuring and related costs (1) (8.0) (18.5) Acquisition and integration planning costs (2) (6.2) (0.5) Gain on sale of Infant and Pet Care business 5.2 — Feminine and Infant Care evaluation costs (3) (0.3) — Sun Care reformulation costs (4) — (0.1) Investor settlement expense (5) — (0.9) Amortization of intangibles (4.3) (4.5) Interest and other expense, net (12.7) (17.3) Total earnings before income taxes $ 29.6 $ 7.6 (1) Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel. (2) Includes pre-tax SG&A of $6.2 and $0.5 for the three months ended December 31, 2019 and 2018, respectively, related to acquisition and integration planning costs. (3) Includes pre-tax SG&A of $0.3 for the three months ended December 31, 2019. (4) Includes pre-tax Cost of products sold of $0.1 for the three months ended December 31, 2018. (5) Includes pre-tax SG&A of $0.9 for the three months ended December 31, 2018. The following table presents the Company’s net sales by geographic area: Three Months Ended December 31, 2019 2018 Net Sales to Customers United States $ 251.1 $ 251.3 International 202.9 205.8 Total net sales $ 454.0 $ 457.1 Supplemental product information is presented below for net sales: Three Months Ended 2019 2018 Razors and blades $ 244.3 $ 255.3 Tampons, pads, and liners 75.1 74.7 Skin care products 37.9 33.5 Sun care products 37.2 33.2 Shaving gels and creams 32.7 32.4 Infant care and other 26.8 28.0 Total net sales $ 454.0 $ 457.1

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	3 Months Ended
	Dec. 31, 2019
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	Guarantor and Non-Guarantor Financial InformationSet forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of Edgewell Personal Care Company (the “Parent Company”), the Company’s existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company’s credit agreements or other indebtedness for borrowed money (the “Guarantors”), the Company’s subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company’s other indebtedness (the “Non-Guarantors”) on a combined basis and eliminations necessary to arrive at the information for the Company as reported, on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 296.1 $ 234.2 $ (76.3) $ 454.0 Cost of products sold — 189.3 147.9 (76.3) 260.9 Gross profit — 106.8 86.3 — 193.1 Selling, general and administrative expense — 59.1 35.9 — 95.0 Advertising and sales promotion expense — 20.2 20.9 — 41.1 Research and development expense — 13.8 — — 13.8 Restructuring charges — 3.1 3.0 — 6.1 Gain on sale of Infant and Pet Care business — (5.2) — — (5.2) Interest expense associated with debt 13.3 0.8 0.2 — 14.3 Other (income) expense, net — 0.8 (2.4) — (1.6) Intercompany service fees — (3.1) 3.1 — — Equity in earnings of subsidiaries (32.3) (21.2) — 53.5 — Earnings before income taxes 19.0 38.5 25.6 (53.5) 29.6 Income tax provision (benefit) (3.4) 6.2 4.4 — 7.2 Net earnings $ 22.4 $ 32.3 $ 21.2 $ (53.5) $ 22.4 Statements of Comprehensive Income: Net earnings $ 22.4 $ 32.3 $ 21.2 $ (53.5) $ 22.4 Other comprehensive income, net of tax 18.7 18.7 19.7 (38.4) 18.7 Total comprehensive income $ 41.1 $ 51.0 $ 40.9 $ (91.9) $ 41.1 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 299.7 $ 236.7 $ (79.3) $ 457.1 Cost of products sold — 192.8 150.1 (79.3) 263.6 Gross profit — 106.9 86.6 — 193.5 Selling, general and administrative expense — 51.2 36.1 — 87.3 Advertising and sales promotion expense — 27.4 24.2 — 51.6 Research and development expense — 12.6 — — 12.6 Restructuring charges — 8.9 8.2 — 17.1 Interest expense associated with debt 13.4 2.5 0.1 — 16.0 Other expense, net — 0.6 0.7 — 1.3 Intercompany service fees — (3.6) 3.6 — — Equity in earnings of subsidiaries (9.7) (11.5) — 21.2 — Earnings (loss) before income taxes (3.7) 18.8 13.7 (21.2) 7.6 Income tax provision (benefit) (3.3) 9.1 2.2 — 8.0 Net (loss) earnings $ (0.4) $ 9.7 $ 11.5 $ (21.2) $ (0.4) Statements of Comprehensive Loss: Net (loss) earnings $ (0.4) $ 9.7 $ 11.5 $ (21.2) $ (0.4) Other comprehensive loss, net of tax (12.1) (12.1) (11.6) 23.7 (12.1) Total comprehensive loss $ (12.5) $ (2.4) $ (0.1) $ 2.5 $ (12.5) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 73.0 $ 178.8 $ — $ 251.8 Trade receivables, net — 44.1 139.1 — 183.2 Inventories — 198.8 168.2 — 367.0 Other current assets — 63.3 81.3 — 144.6 Total current assets — 379.2 567.4 — 946.6 Investment in subsidiaries 3,411.8 1,018.7 — (4,430.5) — Intercompany receivables, net (1) — 892.6 66.8 (959.4) — Property, plant and equipment, net — 279.5 105.3 — 384.8 Goodwill — 733.0 297.8 — 1,030.8 Other intangible assets, net — 639.2 204.5 — 843.7 Other assets 0.3 28.0 69.0 — 97.3 Total assets $ 3,412.1 $ 3,970.2 $ 1,310.8 $ (5,389.9) $ 3,303.2 Liabilities and Shareholders' Equity Current liabilities $ 6.5 $ 256.9 $ 199.1 $ — $ 462.5 Intercompany payables, net (1) 959.4 — — (959.4) — Long-term debt 1,098.1 — — — 1,098.1 Deferred income tax liabilities — 71.7 12.3 — 84.0 Other liabilities — 229.8 80.7 — 310.5 Total liabilities 2,064.0 558.4 292.1 (959.4) 1,955.1 Total shareholders' equity 1,348.1 3,411.8 1,018.7 (4,430.5) 1,348.1 Total liabilities and shareholders' equity $ 3,412.1 $ 3,970.2 $ 1,310.8 $ (5,389.9) $ 3,303.2 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 2.6 $ 339.0 $ — $ 341.6 Trade receivables, net — 43.7 161.9 — 205.6 Inventories — 193.1 164.1 — 357.2 Other current assets — 59.7 80.3 — 140.0 Total current assets — 299.1 745.3 — 1,044.4 Investment in subsidiaries 3,357.4 1,139.6 — (4,497.0) — Intercompany receivables, net (1) — 878.7 58.2 (936.9) — Property, plant and equipment, net — 292.1 103.9 — 396.0 Goodwill — 741.0 291.8 — 1,032.8 Other intangible assets, net — 711.8 201.1 — 912.9 Other assets 0.4 0.2 34.2 — 34.8 Total assets $ 3,357.8 $ 4,062.5 $ 1,434.5 $ (5,433.9) $ 3,420.9 Liabilities and Shareholders’ Equity Current liabilities $ 19.6 $ 409.7 $ 230.3 $ — $ 659.6 Intercompany payables, net (1) 936.9 — — (936.9) — Long-term debt 1,097.8 — — — 1,097.8 Deferred income tax liabilities — 88.7 12.4 — 101.1 Other liabilities — 206.7 52.2 — 258.9 Total liabilities 2,054.3 705.1 294.9 (936.9) 2,117.4 Total shareholders’ equity 1,303.5 3,357.4 1,139.6 (4,497.0) 1,303.5 Total liabilities and shareholders’ equity $ 3,357.8 $ 4,062.5 $ 1,434.5 $ (5,433.9) $ 3,420.9 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ (21.0) $ 135.4 $ 1.8 $ (163.1) $ (46.9) Cash Flow from Investing Activities Capital expenditures — (4.7) (2.9) — (7.6) Proceeds from sale of Infant and Pet Care business — 95.8 — — 95.8 Collection of deferred purchase price from accounts receivable sold — 2.8 — — 2.8 Proceeds from sale of assets — — — — — Intercompany receivable/payable, net — (22.5) — 22.5 — Other, net — — (1.3) — (1.3) Net cash from (used by) investing activities — 71.4 (4.2) 22.5 89.7 Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 50.0 — — 50.0 Cash payments on debt with original maturities greater than 90 days — (167.0) — — (167.0) Net (decrease) increase in debt with original maturities of 90 days or less — (2.1) 2.0 — (0.1) Intercompany receivable/payable, net 22.5 — — (22.5) — Intercompany dividends — — (163.1) 163.1 — Net financing outflow from the Accounts Receivable Facility — (14.9) — — (14.9) Employee shares withheld for taxes (1.5) — — — (1.5) Other, net — (2.4) — — (2.4) Net cash from (used by) financing activities 21.0 (136.4) (161.1) 140.6 (135.9) Effect of exchange rate changes on cash — — 3.3 — 3.3 Net increase (decrease) in cash and cash equivalents — 70.4 (160.2) — (89.8) Cash and cash equivalents, beginning of period — 2.6 339.0 — 341.6 Cash and cash equivalents, end of period — 73.0 178.8 — 251.8 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ 1.5 $ (24.6) $ 21.7 $ (45.0) $ (46.4) Cash Flow from Investing Activities Capital expenditures — (6.5) (2.9) — (9.4) Collection of deferred purchase price from accounts receivable sold — 2.5 — — 2.5 Proceeds from sale of assets — 4.0 — — 4.0 Net cash used by investing activities — — (2.9) — (2.9) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 137.0 — — 137.0 Cash payments on debt with original maturities greater than 90 days — (105.0) — — (105.0) Net (decrease) increase in debt with original maturities of 90 days or less — (2.6) 1.7 — (0.9) Intercompany dividend — — (45.0) 45.0 — Net financing outflow from the Accounts Receivable Facility — (5.1) — — (5.1) Employee shares withheld for taxes (1.5) — — — (1.5) Net cash from (used by) financing activities (1.5) 24.3 (43.3) 45.0 24.5 Effect of exchange rate changes on cash — — (1.7) — (1.7) Net decrease in cash and cash equivalents — (0.3) (26.2) — (26.5) Cash and cash equivalents, beginning of period — 2.5 263.9 — 266.4 Cash and cash equivalents, end of period $ — $ 2.2 $ 237.7 $ — $ 239.9

Subsequent Events

Subsequent Events	3 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent events	Subsequent Event Harry's Acquisition On May 9, 2019, the Company announced that it had entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which the Company would combine with Harry’s in a cash and stock transaction that valued Harry’s at $1,370.0 (the “Merger”). The Merger was approved by the Boards of Directors of both our Company and Harry’s. On February 9, 2020, following the U.S Federal Trade Commission’s (“FTC”) lawsuit seeking to block the proposed transaction, the Company terminated its merger agreement with Harry’s. Harry’s has informed the Company that it intends to pursue litigation. The Company believes that such litigation has no merit. Following termination of the Merger Agreement, the previously announced commitment letter between the Company and Bank of America Merrill Lynch pursuant to which Bank of America Merrill Lynch committed to provide a senior secured revolving credit facility and senior secured term loans in connection with the Merger has also been terminated. The Company incurred costs associated with the combination with Harry’s totaling $6.2 for the three months ended December 31, 2019, which were included in SG&A on the Consolidated Statement of Earnings.

Restructuring Charges (Tables)

Restructuring Charges (Tables)	3 Months Ended
	Dec. 31, 2019
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	The Company does not include Project Fuel restructuring costs in the results of its reportable segments. The estimated impact of allocating such charges to segment results for fiscal 2020 would have been as follows: Three Months Ended December 31, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ — $ — $ — $ — $ 1.3 1.3 Asset impairment and accelerated depreciation — — — — — — Consulting, project implementation and management, and other exit costs 2.8 — — — 3.9 6.7 Total Restructuring $ 2.8 $ — $ — $ — $ 5.2 $ 8.0 Three Months Ended December 31, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 7.3 $ 0.5 $ 0.3 $ 0.1 $ 1.0 $ 9.2 Asset impairment and accelerated depreciation — — — — 0.5 0.5 Consulting, project implementation and management, and other exit costs 2.3 — — — 6.5 8.8 Total Restructuring $ 9.6 $ 0.5 $ 0.3 $ 0.1 $ 8.0 $ 18.5
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2020: Utilized October 1, 2019 Charge to Other (1) Cash Non-Cash December 31, Restructuring Severance and related benefit costs $ 8.2 $ 1.3 $ — $ (2.6) $ — $ 6.9 Asset impairment and accelerated depreciation — — — — — — Consulting, project implementation and management, and other exit costs 1.3 6.7 — (6.4) — 1.6 Total Restructuring $ 9.5 $ 8.0 $ — $ (9.0) $ — $ 8.5 (1) Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
	Dec. 31, 2019
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended 2019 2018 Basic weighted-average shares outstanding 54.3 54.1 Effect of dilutive securities: RSE awards 0.1 — Total dilutive securities 0.1 — Diluted weighted-average shares outstanding 54.4 54.1

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Gross balance at October 1, 2019 $ 960.3 $ 228.3 $ 207.0 $ 69.6 $ 1,465.2 Accumulated goodwill impairment (369.0) (2.0) — (61.4) (432.4) Net balance at October 1, 2019 $ 591.3 $ 226.3 $ 207.0 $ 8.2 $ 1,032.8 Changes in the three-month period ended December 31, 2019 Infant and Pet Care divestiture — — — (8.2) (8.2) Cumulative translation adjustment 4.2 1.2 0.8 — 6.2 Gross balance at December 31, 2019 $ 964.5 $ 229.5 $ 207.8 $ 61.4 $ 1,463.2 Accumulated goodwill impairment (369.0) (2.0) — (61.4) (432.4) Net balance at December 31, 2019 $ 595.5 $ 227.5 $ 207.8 $ — $ 1,030.8
Schedule of Amortizable Intangible Assets	December 31, 2019 September 30, 2019 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.5 $ 37.6 $ 168.9 $ 206.4 $ 35.0 $ 171.4 Technology and patents 76.2 74.5 1.7 78.5 76.4 2.1 Customer related and other 178.4 103.4 75.0 176.0 100.9 75.1 Total amortizable intangible assets $ 461.1 $ 215.5 $ 245.6 $ 460.9 $ 212.3 $ 248.6

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2019
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	December 31, September 30, Inventories Raw materials and supplies $ 58.9 $ 55.1 Work in process 63.0 66.5 Finished products 245.1 235.6 Total inventories $ 367.0 $ 357.2 Other Current Assets Miscellaneous receivables $ 23.0 $ 14.9 Inventory returns receivable 0.6 4.9 Prepaid expenses 68.1 65.0 Value added tax collectible from customers 19.7 23.0 Income taxes receivable 16.0 29.1 Other 17.2 3.1 Total other current assets $ 144.6 $ 140.0 Property, Plant and Equipment Land $ 18.9 $ 18.7 Buildings 137.5 137.4 Machinery and equipment 991.8 992.3 Capitalized software costs 46.3 47.8 Construction in progress 40.4 40.9 Total gross property, plant and equipment 1,234.9 1,237.1 Accumulated depreciation and amortization (850.1) (841.1) Total property, plant and equipment, net $ 384.8 $ 396.0 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 41.7 $ 51.9 Accrued trade allowances 23.4 26.2 Accrued salaries, vacations and incentive compensation 34.7 51.5 Income taxes payable 19.6 11.5 Returns reserve 27.0 60.4 Restructuring reserve 8.5 9.5 Value added tax payable 3.0 3.6 Deferred compensation 6.4 10.4 Short term lease obligation 12.0 — Customer advance payments 1.5 1.7 Other 72.6 78.7 Total other current liabilities $ 250.4 $ 305.4 Other Liabilities Pensions and other retirement benefits $ 149.1 $ 149.8 Deferred compensation 33.7 30.3 Long term lease obligation 43.6 — Other non-current liabilities 84.1 78.8 Total other liabilities $ 310.5 $ 258.9

Leases (Tables)

Leases (Tables)	3 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Summary of Lease Information	A summary of the company's lease information is as follows: Classification December 31, Assets Right of use assets Other assets $ 55.7 Liabilities Current lease liabilities Other current liabilities $ 12.0 Long-term lease liabilities Other liabilities 43.6 Total lease liabilities $ 55.6 Other information Weighted-average remaining lease term (years) 11 Weighted-average incremental borrowing rate 7.0 % Three Months Ended December 31, 2019 Statement of Income Lease cost (1) $ 3.7 Other information Leased assets obtained in exchange for new lease liabilities $ 0.1 Cash paid for amounts included in the measurement of lease liabilities $ 3.8
Lessee, Operating Lease, Liability, Maturity	The Company's minimum annual rentals including reasonable assured renewal options under lease agreements are as follows: Operating 2020 $ 10.7 2021 10.7 2022 8.1 2023 6.7 2024 5.3 2025 and thereafter 42.4 Total future minimum lease commitments 83.9 Less: Imputed Interest (28.3) Present value of lease liabilities $ 55.6 At September 30, 2019, the aggregate future minimum rental commitments under all non-cancelable operating lease agreements were as follows: Operating Leases 2020 $ 13.6 2021 10.5 2022 7.4 2023 5.9 2024 4.6 2025 and thereafter 12.5 Total future minimum lease commitments 54.5

Debt (Tables)

Debt (Tables)	3 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021 $ 600.0 $ 600.0 Senior notes, fixed interest rate of 4.7%, due 2022 500.0 500.0 U.S. revolving credit facility due 2020 — 117.0 Total long-term debt, including current maturities 1,100.0 1,217.0 Less current portion — 117.0 Less unamortized debt issuance costs and discount (1) (2) 1.9 2.2 Total long-term debt $ 1,098.1 $ 1,097.8 (1) At December 31, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.6 and $1.0, respectively. At September 30, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.8 and $1.0, respectively. (2) At December 31, 2019 and September 30, 2019, the balance for the senior notes due 2022 was reflected net of discount of $0.3 and $0.4, respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	3 Months Ended
	Dec. 31, 2019
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement cost for these plans was as follows: Three Months Ended 2019 2018 Service cost $ 1.1 $ 0.7 Interest cost 3.4 4.7 Expected return on plan assets (5.8) (6.3) Recognized net actuarial loss 2.3 1.0 Settlement loss recognized 0.2 — Net periodic cost $ 1.2 $ 0.1

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive (loss) income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2019 $ (77.3) $ (159.8) $ 1.2 $ (235.9) OCI before reclassifications (1) 21.5 (3.3) (0.7) 17.5 Reclassifications to earnings — 1.8 (0.6) 1.2 Balance at December 31, 2019 $ (55.8) $ (161.3) $ (0.1) $ (217.2) Foreign Pension and Hedging Total Balance at October 1, 2018 $ (40.6) $ (110.3) $ 2.6 $ (148.3) OCI before reclassifications (1) (10.8) (0.7) (0.1) (11.6) Reclassifications to earnings — 0.7 (1.2) (0.5) Balance at December 31, 2018 $ (51.4) $ (110.3) $ 1.3 $ (160.4) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: For the Three Months Ended Affected Line Item in the Details of AOCI Components 2019 2018 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 0.9 $ 1.8 Other (income) expense, net 0.9 1.8 Total before tax 0.3 0.6 Income tax provision 0.6 1.2 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses $ (2.3) $ (1.0) (1) Settlements (0.2) — (2.5) (1.0) Total before tax (0.7) (0.3) Income tax provision (1.8) (0.7) Net of tax Total reclassifications for the period $ (1.2) $ 0.5 Net of tax (1) These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	3 Months Ended
	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) December 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (0.1) $ 1.7 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.2 $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended December 31, 2019 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Loss recognized in OCI (1) $ (0.9) $ (0.2) Gain reclassified from AOCI into income (effective portion) (1) (2) 0.9 1.8 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 0.3 $ (1.3) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At December 31, 2019 At September 30, 2019 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 1.0 $ (0.7) $ 2.4 $ (0.5) Gross amounts offset in the balance sheet (0.2) — — 0.2 Net amounts of assets (liabilities) presented in the balance sheet $ 0.8 $ (0.7) $ 2.4 $ (0.3) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: December 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (40.1) $ (40.6) Derivatives - foreign currency contracts 0.1 2.1 Net liabilities at estimated fair value $ (40.0) $ (38.5)

Segment Data (Tables)

Segment Data (Tables)	3 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended 2019 2018 Net Sales Wet Shave $ 277.0 $ 287.7 Sun and Skin Care 75.1 66.7 Feminine Care 75.1 74.7 All Other 26.8 28.0 Total net sales $ 454.0 $ 457.1 Segment Profit Wet Shave $ 52.9 $ 55.0 Sun and Skin Care 0.1 (0.6) Feminine Care 13.1 7.5 All Other 3.1 1.2 Total segment profit 69.2 63.1 General corporate and other expenses (13.3) (13.7) Restructuring and related costs (1) (8.0) (18.5) Acquisition and integration planning costs (2) (6.2) (0.5) Gain on sale of Infant and Pet Care business 5.2 — Feminine and Infant Care evaluation costs (3) (0.3) — Sun Care reformulation costs (4) — (0.1) Investor settlement expense (5) — (0.9) Amortization of intangibles (4.3) (4.5) Interest and other expense, net (12.7) (17.3) Total earnings before income taxes $ 29.6 $ 7.6 (1) Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel. (2) Includes pre-tax SG&A of $6.2 and $0.5 for the three months ended December 31, 2019 and 2018, respectively, related to acquisition and integration planning costs. (3) Includes pre-tax SG&A of $0.3 for the three months ended December 31, 2019. (4) Includes pre-tax Cost of products sold of $0.1 for the three months ended December 31, 2018. (5) Includes pre-tax SG&A of $0.9 for the three months ended December 31, 2018.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended December 31, 2019 2018 Net Sales to Customers United States $ 251.1 $ 251.3 International 202.9 205.8 Total net sales $ 454.0 $ 457.1
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended 2019 2018 Razors and blades $ 244.3 $ 255.3 Tampons, pads, and liners 75.1 74.7 Skin care products 37.9 33.5 Sun care products 37.2 33.2 Shaving gels and creams 32.7 32.4 Infant care and other 26.8 28.0 Total net sales $ 454.0 $ 457.1

Guarantor and Non-Guarantor F_2

Guarantor and Non-Guarantor Financial Information (Tables)	3 Months Ended
	Dec. 31, 2019
Guarantor and Non-Guarantor Financial Information [Abstract]
Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 296.1 $ 234.2 $ (76.3) $ 454.0 Cost of products sold — 189.3 147.9 (76.3) 260.9 Gross profit — 106.8 86.3 — 193.1 Selling, general and administrative expense — 59.1 35.9 — 95.0 Advertising and sales promotion expense — 20.2 20.9 — 41.1 Research and development expense — 13.8 — — 13.8 Restructuring charges — 3.1 3.0 — 6.1 Gain on sale of Infant and Pet Care business — (5.2) — — (5.2) Interest expense associated with debt 13.3 0.8 0.2 — 14.3 Other (income) expense, net — 0.8 (2.4) — (1.6) Intercompany service fees — (3.1) 3.1 — — Equity in earnings of subsidiaries (32.3) (21.2) — 53.5 — Earnings before income taxes 19.0 38.5 25.6 (53.5) 29.6 Income tax provision (benefit) (3.4) 6.2 4.4 — 7.2 Net earnings $ 22.4 $ 32.3 $ 21.2 $ (53.5) $ 22.4 Statements of Comprehensive Income: Net earnings $ 22.4 $ 32.3 $ 21.2 $ (53.5) $ 22.4 Other comprehensive income, net of tax 18.7 18.7 19.7 (38.4) 18.7 Total comprehensive income $ 41.1 $ 51.0 $ 40.9 $ (91.9) $ 41.1 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 299.7 $ 236.7 $ (79.3) $ 457.1 Cost of products sold — 192.8 150.1 (79.3) 263.6 Gross profit — 106.9 86.6 — 193.5 Selling, general and administrative expense — 51.2 36.1 — 87.3 Advertising and sales promotion expense — 27.4 24.2 — 51.6 Research and development expense — 12.6 — — 12.6 Restructuring charges — 8.9 8.2 — 17.1 Interest expense associated with debt 13.4 2.5 0.1 — 16.0 Other expense, net — 0.6 0.7 — 1.3 Intercompany service fees — (3.6) 3.6 — — Equity in earnings of subsidiaries (9.7) (11.5) — 21.2 — Earnings (loss) before income taxes (3.7) 18.8 13.7 (21.2) 7.6 Income tax provision (benefit) (3.3) 9.1 2.2 — 8.0 Net (loss) earnings $ (0.4) $ 9.7 $ 11.5 $ (21.2) $ (0.4) Statements of Comprehensive Loss: Net (loss) earnings $ (0.4) $ 9.7 $ 11.5 $ (21.2) $ (0.4) Other comprehensive loss, net of tax (12.1) (12.1) (11.6) 23.7 (12.1) Total comprehensive loss $ (12.5) $ (2.4) $ (0.1) $ 2.5 $ (12.5)
Schedule of Condensed Consolidating Balance Sheets	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 73.0 $ 178.8 $ — $ 251.8 Trade receivables, net — 44.1 139.1 — 183.2 Inventories — 198.8 168.2 — 367.0 Other current assets — 63.3 81.3 — 144.6 Total current assets — 379.2 567.4 — 946.6 Investment in subsidiaries 3,411.8 1,018.7 — (4,430.5) — Intercompany receivables, net (1) — 892.6 66.8 (959.4) — Property, plant and equipment, net — 279.5 105.3 — 384.8 Goodwill — 733.0 297.8 — 1,030.8 Other intangible assets, net — 639.2 204.5 — 843.7 Other assets 0.3 28.0 69.0 — 97.3 Total assets $ 3,412.1 $ 3,970.2 $ 1,310.8 $ (5,389.9) $ 3,303.2 Liabilities and Shareholders' Equity Current liabilities $ 6.5 $ 256.9 $ 199.1 $ — $ 462.5 Intercompany payables, net (1) 959.4 — — (959.4) — Long-term debt 1,098.1 — — — 1,098.1 Deferred income tax liabilities — 71.7 12.3 — 84.0 Other liabilities — 229.8 80.7 — 310.5 Total liabilities 2,064.0 558.4 292.1 (959.4) 1,955.1 Total shareholders' equity 1,348.1 3,411.8 1,018.7 (4,430.5) 1,348.1 Total liabilities and shareholders' equity $ 3,412.1 $ 3,970.2 $ 1,310.8 $ (5,389.9) $ 3,303.2 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 2.6 $ 339.0 $ — $ 341.6 Trade receivables, net — 43.7 161.9 — 205.6 Inventories — 193.1 164.1 — 357.2 Other current assets — 59.7 80.3 — 140.0 Total current assets — 299.1 745.3 — 1,044.4 Investment in subsidiaries 3,357.4 1,139.6 — (4,497.0) — Intercompany receivables, net (1) — 878.7 58.2 (936.9) — Property, plant and equipment, net — 292.1 103.9 — 396.0 Goodwill — 741.0 291.8 — 1,032.8 Other intangible assets, net — 711.8 201.1 — 912.9 Other assets 0.4 0.2 34.2 — 34.8 Total assets $ 3,357.8 $ 4,062.5 $ 1,434.5 $ (5,433.9) $ 3,420.9 Liabilities and Shareholders’ Equity Current liabilities $ 19.6 $ 409.7 $ 230.3 $ — $ 659.6 Intercompany payables, net (1) 936.9 — — (936.9) — Long-term debt 1,097.8 — — — 1,097.8 Deferred income tax liabilities — 88.7 12.4 — 101.1 Other liabilities — 206.7 52.2 — 258.9 Total liabilities 2,054.3 705.1 294.9 (936.9) 2,117.4 Total shareholders’ equity 1,303.5 3,357.4 1,139.6 (4,497.0) 1,303.5 Total liabilities and shareholders’ equity $ 3,357.8 $ 4,062.5 $ 1,434.5 $ (5,433.9) $ 3,420.9 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.
Schedule of Condensed Consolidating Statements of Cash Flows	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ (21.0) $ 135.4 $ 1.8 $ (163.1) $ (46.9) Cash Flow from Investing Activities Capital expenditures — (4.7) (2.9) — (7.6) Proceeds from sale of Infant and Pet Care business — 95.8 — — 95.8 Collection of deferred purchase price from accounts receivable sold — 2.8 — — 2.8 Proceeds from sale of assets — — — — — Intercompany receivable/payable, net — (22.5) — 22.5 — Other, net — — (1.3) — (1.3) Net cash from (used by) investing activities — 71.4 (4.2) 22.5 89.7 Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 50.0 — — 50.0 Cash payments on debt with original maturities greater than 90 days — (167.0) — — (167.0) Net (decrease) increase in debt with original maturities of 90 days or less — (2.1) 2.0 — (0.1) Intercompany receivable/payable, net 22.5 — — (22.5) — Intercompany dividends — — (163.1) 163.1 — Net financing outflow from the Accounts Receivable Facility — (14.9) — — (14.9) Employee shares withheld for taxes (1.5) — — — (1.5) Other, net — (2.4) — — (2.4) Net cash from (used by) financing activities 21.0 (136.4) (161.1) 140.6 (135.9) Effect of exchange rate changes on cash — — 3.3 — 3.3 Net increase (decrease) in cash and cash equivalents — 70.4 (160.2) — (89.8) Cash and cash equivalents, beginning of period — 2.6 339.0 — 341.6 Cash and cash equivalents, end of period — 73.0 178.8 — 251.8 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ 1.5 $ (24.6) $ 21.7 $ (45.0) $ (46.4) Cash Flow from Investing Activities Capital expenditures — (6.5) (2.9) — (9.4) Collection of deferred purchase price from accounts receivable sold — 2.5 — — 2.5 Proceeds from sale of assets — 4.0 — — 4.0 Net cash used by investing activities — — (2.9) — (2.9) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 137.0 — — 137.0 Cash payments on debt with original maturities greater than 90 days — (105.0) — — (105.0) Net (decrease) increase in debt with original maturities of 90 days or less — (2.6) 1.7 — (0.9) Intercompany dividend — — (45.0) 45.0 — Net financing outflow from the Accounts Receivable Facility — (5.1) — — (5.1) Employee shares withheld for taxes (1.5) — — — (1.5) Net cash from (used by) financing activities (1.5) 24.3 (43.3) 45.0 24.5 Effect of exchange rate changes on cash — — (1.7) — (1.7) Net decrease in cash and cash equivalents — (0.3) (26.2) — (26.5) Cash and cash equivalents, beginning of period — 2.5 263.9 — 266.4 Cash and cash equivalents, end of period $ — $ 2.2 $ 237.7 $ — $ 239.9

Background and Basis of Prese_2

Background and Basis of Presentation (Details) $ in Millions	Dec. 31, 2019USD ($)country	Oct. 01, 2019USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates | country	20
Number of countries with retail operations | country	50
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use asset	$ 55.7
Operating lease, liability	$ 55.6
Accounting standards update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use asset		$ 57.4
Operating lease, liability		$ 57.5

Divestitures (Details)

Divestitures (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 17, 2019
Divestiture
Proceeds from sale of Infant and Pet Care business	$ 95.8	$ 0
Gain on sale of Infant and Pet Care business	(5.2)	$ 0
Infant and Pet Care | Disposal group, not discontinued operations
Divestiture
Divestiture, sale price	122.5
Proceeds from sale of Infant and Pet Care business	107.5
Proceeds from sale receivable, current			$ 7.5
Proceeds from sale receivable, noncurrent			5
Disposal, inventory			19.5
Disposal, fixed assets			3.2
Disposal, goodwill and intangible assets			$ 77.8
Gain on sale of Infant and Pet Care business	$ 5.2

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold	[1]	$ 8	$ 18.5
Project Fuel
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		1.3	9.2
Asset impairment and accelerated depreciation		0	0.5
Consulting, project implementation and management, and other exit costs		6.7	8.8
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		8	18.5
Project Fuel | Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	7.3
Asset impairment and accelerated depreciation		0	0
Consulting, project implementation and management, and other exit costs		2.8	2.3
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		2.8	9.6
Project Fuel | Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	0.5
Asset impairment and accelerated depreciation		0	0
Consulting, project implementation and management, and other exit costs		0	0
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		0	0.5
Project Fuel | Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	0.3
Asset impairment and accelerated depreciation		0	0
Consulting, project implementation and management, and other exit costs		0	0
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		0	0.3
Project Fuel | All Other
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	0.1
Asset impairment and accelerated depreciation		0	0
Consulting, project implementation and management, and other exit costs		0	0
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		0	0.1
Project Fuel | Corporate
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		1.3	1
Asset impairment and accelerated depreciation		0	0.5
Consulting, project implementation and management, and other exit costs		3.9	6.5
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		5.2	8
IT enablement | Selling, general and administrative expenses | Project Fuel
Restructuring Cost and Reserve [Line Items]
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses and Cost of Product Sold		$ 1.9	$ 1.4
[1]	Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel.

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Restructuring Reserve [Roll Forward]
Restructuring and related costs	[1]	$ 8	$ 18.5
Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance		9.5
Restructuring and related costs		8	$ 18.5
Other	[2]	0
Utilized - Cash Payments		(9)
Utilized - Non-Cash		0
Ending Balance		8.5
Employee Severance [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance		8.2
Restructuring and related costs		1.3
Other	[2]	0
Utilized - Cash Payments		(2.6)
Utilized - Non-Cash		0
Ending Balance		6.9
Asset Impairment and Accelerated Depreciation [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance		0
Restructuring and related costs		0
Other	[2]	0
Utilized - Cash Payments		0
Utilized - Non-Cash		0
Ending Balance		0
Other Restructuring [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance		1.3
Restructuring and related costs		6.7
Other	[2]	0
Utilized - Cash Payments		(6.4)
Utilized - Non-Cash		0
Ending Balance		$ 1.6
[1]	Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel.
[2]	Includes the impact of currency translation.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Earnings before income taxes		$ 29.6	$ 7.6
Effective tax rate		24.40%	105.70%
Income tax provision		$ 7.2	$ 8
Restructuring and related costs	[1]	8	18.5
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision		7.2	8
US Tax Act
Income Tax Disclosure [Abstract]
Income tax provision			4.7
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision			4.7
Project Fuel
Income Tax Disclosure [Abstract]
Restructuring and related costs		$ 8	$ 18.5
[1]	Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel.

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	54.3	54.1
Effect of dilutive securities (in shares)	0.1	0
Diluted weighted-average shares outstanding (in shares)	54.4	54.1
RSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.1	0
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.1	0.2

Earnings per Share (Narrative)

Earnings per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.7	0.6
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.1	0.2

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019
Goodwill [Line Items]
Goodwill, Gross	$ 1,463.2	$ 1,465.2
Accumulated goodwill impairment loss	432.4	432.4
Goodwill [Roll Forward]
Beginning balance	1,032.8
Infant and Pet Care divestiture	8.2
Cumulative translation adjustment	(6.2)
Ending balance	1,030.8	1,032.8
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	964.5	960.3
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	591.3
Infant and Pet Care divestiture	0
Cumulative translation adjustment	(4.2)
Ending balance	595.5	591.3
Impairment loss		369
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	229.5	228.3
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	226.3
Infant and Pet Care divestiture	0
Cumulative translation adjustment	(1.2)
Ending balance	227.5	226.3
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	207.8	207
Accumulated goodwill impairment loss	0	0
Goodwill [Roll Forward]
Beginning balance	207
Infant and Pet Care divestiture	0
Cumulative translation adjustment	(0.8)
Ending balance	207.8	207
All Other
Goodwill [Line Items]
Goodwill, Gross	61.4	69.6
Accumulated goodwill impairment loss	61.4	61.4
Goodwill [Roll Forward]
Beginning balance	8.2
Infant and Pet Care divestiture	8.2
Cumulative translation adjustment	0
Ending balance	$ 0	8.2
Skin Care
Goodwill [Roll Forward]
Impairment loss		2
Infant Care
Goodwill [Roll Forward]
Impairment loss		37
Wet Ones
Indefinite-lived Intangible Assets [Line Items]
Indefinite lived intangible impairment		87
Diaper Genie
Indefinite-lived Intangible Assets [Line Items]
Indefinite lived intangible impairment		$ 75

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 461.1		$ 460.9
Amortizable intangible assets, accumulated amortization	215.5		212.3
Amortizable intangible assets, net	245.6		248.6
Amortization of intangibles	4.3	$ 4.5
Amortizable intangible assets, amortization expense, remainder of 2020	12.7
Amortizable intangible assets, amortization expense, fiscal 2021	16.5
Amortizable intangible assets, amortization expense, fiscal 2022	16.4
Amortizable intangible assets, amortization expense, fiscal 2023	16.4
Amortizable intangible assets, amortization expense, fiscal 2024	16.3
Amortizable intangible assets, amortization expense, fiscal 2025	16.3
Amortizable intangible assets, amortization expense, thereafter	151
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	206.5		206.4
Amortizable intangible assets, accumulated amortization	37.6		35
Amortizable intangible assets, net	168.9		171.4
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	76.2		78.5
Amortizable intangible assets, accumulated amortization	74.5		76.4
Amortizable intangible assets, net	1.7		2.1
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	178.4		176
Amortizable intangible assets, accumulated amortization	103.4		100.9
Amortizable intangible assets, net	$ 75		$ 75.1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 598.2	$ 664.3
Indefinite-lived intangible assets, increase	(66.1)
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	179.7	177.7
Impairment loss		369
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	388.6	387.9
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	29.9	29.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 0	$ 68.8

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2019	Sep. 30, 2019
Inventories
Raw materials and supplies	$ 58.9	$ 55.1
Work in process	63	66.5
Finished products	245.1	235.6
Total inventories	367	357.2
Other Current Assets
Miscellaneous receivables	23	14.9
Inventory returns receivable	0.6	4.9
Prepaid expenses	68.1	65
Value added tax collectible from customers	19.7	23
Income taxes receivable	16	29.1
Other	17.2	3.1
Total other current assets	144.6	140
Property, Plant and Equipment
Land	18.9	18.7
Buildings	137.5	137.4
Machinery and equipment	991.8	992.3
Capitalized software costs	46.3	47.8
Construction in progress	40.4	40.9
Total gross property, plant and equipment	1,234.9	1,237.1
Accumulated depreciation and amortization	(850.1)	(841.1)
Total property, plant and equipment, net	384.8	396
Other Current Liabilities
Accrued advertising, sales promotion and allowances	41.7	51.9
Accrued trade allowances	23.4	26.2
Accrued salaries, vacations and incentive compensation	34.7	51.5
Income taxes payable	19.6	11.5
Returns reserve	27	60.4
Restructuring reserve	8.5	9.5
Value added tax payable	3	3.6
Deferred compensation	6.4	10.4
Short term lease obligation	12	0
Customer advance payments	1.5	1.7
Other	72.6	78.7
Total other current liabilities	250.4	305.4
Other Liabilities
Pensions and other retirement benefits	149.1	149.8
Deferred compensation	33.7	30.3
Long-term income taxes payable	43.6	0
Other non-current liabilities	84.1	78.8
Total other liabilities	$ 310.5	$ 258.9

Leases (Summary of Lease Inform

Leases (Summary of Lease Information) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Sep. 30, 2019
Leases [Abstract]
Operating lease, right-of-use asset		$ 55.7
Short term lease obligation		12	$ 0
Operating lease, liability		55.6
Operating lease, liability, noncurrent		$ 43.6
Operating lease, weighted average remaining lease term		11 years
Operating lease, weighted average discount rate, percent		7.00%
Operating lease, expense	[1]	$ 3.7
Right-of-use asset obtained in exchange for operating lease liability		0.1
Operating lease, payments		$ 3.8
[1]	Lease expense is included in cost of products sold or SG&A expenses based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material.

Leases (Operating Lease Payment

Leases (Operating Lease Payment Schedule) (Details) - USD ($) $ in Millions	Dec. 31, 2019	Sep. 30, 2019
Leases [Abstract]
Lessee, operating lease, payment due current year	$ 10.7
Lessee, operating lease, payment due year two	10.7
Lessee, operating lease, payment due year three	8.1
Lessee, operating lease, payment due year four	6.7
Lessee, operating lease, payment due year five	5.3
Lessee, operating lease, payment due after year five	42.4
Lessee, operating lease, payments due	83.9
Lessee, operating lease, undiscounted excess amount	28.3
Operating lease, liability	$ 55.6
Operating leases, future minimum payments due, next twelve months		$ 13.6
Operating leases, future minimum payments, due in two years		10.5
Operating leases, future minimum payments, due in three years		7.4
Operating leases, future minimum payments, due in four years		5.9
Operating leases, future minimum payments, due in five years		4.6
Operating leases, future minimum payments, due thereafter		12.5
Operating leases, future minimum payments, due		$ 54.5

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of accounts receivable, quarter to date sold	$ 181.7	$ 213.9
Transfer of accounts receivable, sales amount derecognized	67.5		$ 74.9
Loss on sale of accounts receivable	$ 0.5	$ 0.6

Debt (Details)

Debt (Details) - USD ($) $ in Millions		Dec. 31, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,100	$ 1,217
Current maturities of long-term debt		0	117
Unamortized discount and debit issuance costs	[1],[2]	1.9	2.2
Long-term debt		1,098.1	1,097.8
Notes payable		17	14.4
Senior notes | Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities		600	600
Unamortized debt issuance costs		0.6	0.8
Senior notes | Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities		500	500
Unamortized debt issuance costs		1	1
Unamortized discount		0.3	0.4
Domestic line of credit
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 0	$ 117
[1]	At December 31, 2019 and September 30, 2019, the balance for the senior notes due 2022 was reflected net of discount of $0.3 and $0.4, respectively.
[2]	At December 31, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.6 and $1.0, respectively. At September 30, 2019, the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.8 and $1.0, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Retirement Benefits [Abstract]
Service cost	$ 1.1	$ 0.7
Interest cost	3.4	4.7
Expected return on plan assets	(5.8)	(6.3)
Recognized net actuarial loss	2.3	1
Settlement loss recognized	0.2	0
Net periodic cost	$ 1.2	$ 0.1

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (235.9)	$ (148.3)
OCI before reclassifications	[1]	17.5	(11.6)
Reclassifications to earnings		1.2	(0.5)
Ending balance		(217.2)	(160.4)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(77.3)	(40.6)
OCI before reclassifications	[1]	21.5	(10.8)
Reclassifications to earnings		0	0
Ending balance		(55.8)	(51.4)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(159.8)	(110.3)
OCI before reclassifications	[1]	(3.3)	(0.7)
Reclassifications to earnings		1.8	0.7
Ending balance		(161.3)	(110.3)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		1.2	2.6
OCI before reclassifications	[1]	(0.7)	(0.1)
Reclassifications to earnings		(0.6)	(1.2)
Ending balance		$ (0.1)	$ 1.3
[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings		$ (1.2)	$ 0.5
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		0.9	1.8
Gains and losses on cash flow hedges, foreign exchange contracts, tax		0.3	0.6
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		0.6	1.2
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	(2.3)	(1)
Amortization of defined benefit pension and postretirement items, settlement loss, before tax		(0.2)	0
Amortization of defined benefit pension and postretirement items, before tax		(2.5)	(1)
Amortization of defined benefit pension and postretirement items, tax		(0.7)	(0.3)
Amortization of defined benefit pension and postretirement items, after tax		(1.8)	(0.7)
Reclassifications to earnings		(1.2)	0.5
Other (income) expense, net | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 0.9	$ 1.8
[1]	These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended
		Dec. 31, 2019USD ($)contracts	Dec. 31, 2018USD ($)	Sep. 30, 2019USD ($)
Derivative [Line Items]
Long-term debt		$ 1,100		$ 1,217
Fixed rate
Derivative [Line Items]
Long-term debt		1,100
Fair value of long-term debt		$ 1,095.6		1,071.2
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts		5
Derivative, notional amount		$ 39
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ (0.1)		$ 1.7
Open foreign currency contracts | contracts		61
Derivative, notional amount		$ 125
Other (income) expense, net | Not designated as hedge | FX contract
Derivative [Line Items]
Gain (loss) recognized in income	[1]	$ 0.3	$ (1.3)
[1]	Gain (loss) was recorded in Other (income) expense, net.

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Dec. 31, 2019	Sep. 30, 2019
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 0.2	$ 0.4
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ (0.1)	$ 1.7
[1]	All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	[1]	$ (0.9)	$ (0.2)
Other (income) expense, net | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income (effective portion)	[1],[2]	0.9	1.8
Other (income) expense, net | Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	[2]	$ (0.3)	$ 1.3
[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
[2]	Gain (loss) was recorded in Other (income) expense, net.

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Dec. 31, 2019	Sep. 30, 2019
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 1	$ 2.4
Gross amounts of recognized liabilities	[2]	(0.7)	(0.5)
Gross amounts offset in the balance sheet	[1]	(0.2)	0
Gross amounts offset in the balance sheet	[2]	0	0.2
Net amounts of assets presented in the balance sheet	[1]	0.8	2.4
Net amounts of liabilities presented in the balance sheet	[2]	$ (0.7)	$ (0.3)
[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Dec. 31, 2019	Sep. 30, 2019
Derivative [Line Items]
Deferred compensation	$ (40.1)	$ (40.6)
Derivatives - foreign currency contracts	0.1	2.1
Net liabilities at estimated fair value	$ (40)	$ (38.5)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Net sales		$ 454	$ 457.1
Restructuring and related costs	[1]	8	18.5
Acquisition and planning costs	[2]	6.2	0.5
Gain on sale of Infant and Pet Care business		(5.2)	0
Feminine and Infant Care evaluation costs	[3]	0.3	0
Sun Care reformulation costs	[4]	0	0.1
Investor settlement expense	[5]	0	0.9
Amortization of intangibles		4.3	4.5
Interest and other expense, net		12.7	17.3
Earnings before income taxes		29.6	7.6
Wet Shave
Segment Reporting Information [Line Items]
Net sales		277	287.7
Segment profit		52.9	55
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		75.1	66.7
Segment profit		0.1	(0.6)
Feminine Care
Segment Reporting Information [Line Items]
Net sales		75.1	74.7
Segment profit		13.1	7.5
All Other
Segment Reporting Information [Line Items]
Net sales		26.8	28
Segment profit		3.1	1.2
Operating Segments
Segment Reporting Information [Line Items]
Segment profit		69.2	63.1
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		13.3	13.7
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and planning costs		6.2
Cost of products sold
Segment Reporting Information [Line Items]
Sun Care reformulation costs		0.1
Project Fuel
Segment Reporting Information [Line Items]
Restructuring and related costs		8	18.5
Project Fuel | Wet Shave
Segment Reporting Information [Line Items]
Restructuring and related costs		2.8	9.6
Project Fuel | Sun and Skin Care
Segment Reporting Information [Line Items]
Restructuring and related costs		0	0.5
Project Fuel | Feminine Care
Segment Reporting Information [Line Items]
Restructuring and related costs		0	0.3
Project Fuel | All Other
Segment Reporting Information [Line Items]
Restructuring and related costs		0	0.1
Project Fuel | Corporate
Segment Reporting Information [Line Items]
Restructuring and related costs		5.2	8
IT enablement | Project Fuel | Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Restructuring and related costs		$ 1.9	$ 1.4
[1]	Includes pre-tax SG&A of $1.9 and $1.4 for the three months ended December 31, 2019 and 2018, respectively, associated with certain information technology enablement expenses for Project Fuel.
[2]	Includes pre-tax SG&A of $6.2 and $0.5 for the three months ended December 31, 2019 and 2018, respectively, related to acquisition and integration planning costs.
[3]	Includes pre-tax SG&A of $0.3 for the three months ended December 31, 2019.
[4]	Includes pre-tax Cost of products sold of $0.1 for the three months ended December 31, 2018.
[5]	Includes pre-tax SG&A of $0.9 for the three months ended December 31, 2018.

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue from External Customer [Line Items]
Net sales	$ 454	$ 457.1
United States
Revenue from External Customer [Line Items]
Net sales	251.1	251.3
International
Revenue from External Customer [Line Items]
Net sales	$ 202.9	$ 205.8

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue from External Customer [Line Items]
Net sales	$ 454	$ 457.1
Razors and blades
Revenue from External Customer [Line Items]
Net sales	244.3	255.3
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	75.1	74.7
Skin care products
Revenue from External Customer [Line Items]
Net sales	37.9	33.5
Sun care products
Revenue from External Customer [Line Items]
Net sales	37.2	33.2
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	32.7	32.4
Infant care and other
Revenue from External Customer [Line Items]
Net sales	$ 26.8	$ 28

Guarantor and Non-Guarantor F_3

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net sales	$ 454	$ 457.1
Cost of products sold	260.9	263.6
Gross profit	193.1	193.5
Selling, general and administrative expense	95	87.3
Advertising and sales promotion expense	41.1	51.6
Research and development expense	13.8	12.6
Restructuring charges	6.1	17.1
Gain on sale of Infant and Pet Care business	(5.2)	0
Interest expense associated with debt	14.3	16
Other (income) expense, net	(1.6)	1.3
Intercompany service fees	0	0
Equity in earnings of subsidiaries	0	0
Earnings before income taxes	29.6	7.6
Income tax provision	7.2	8
Net earnings (loss)	22.4	(0.4)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings (loss)	22.4	(0.4)
Other comprehensive income, net of tax	18.7	(12.1)
Total comprehensive income	41.1	(12.5)
Intercompany dividend	0	0
Eliminations
Income Statement [Abstract]
Net sales	(76.3)	(79.3)
Cost of products sold	(76.3)	(79.3)
Gross profit	0	0
Selling, general and administrative expense	0	0
Advertising and sales promotion expense	0	0
Research and development expense	0	0
Restructuring charges	0	0
Gain on sale of Infant and Pet Care business	0
Interest expense associated with debt	0	0
Other (income) expense, net	0	0
Intercompany service fees	0	0
Equity in earnings of subsidiaries	53.5	21.2
Earnings before income taxes	(53.5)	(21.2)
Income tax provision	0	0
Net earnings (loss)	(53.5)	(21.2)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings (loss)	(53.5)	(21.2)
Other comprehensive income, net of tax	(38.4)	23.7
Total comprehensive income	(91.9)	2.5
Intercompany dividend	163.1	45
Parent
Income Statement [Abstract]
Net sales	0	0
Cost of products sold	0	0
Gross profit	0	0
Selling, general and administrative expense	0	0
Advertising and sales promotion expense	0	0
Research and development expense	0	0
Restructuring charges	0	0
Gain on sale of Infant and Pet Care business	0
Interest expense associated with debt	13.3	13.4
Other (income) expense, net	0	0
Intercompany service fees	0	0
Equity in earnings of subsidiaries	(32.3)	(9.7)
Earnings before income taxes	19	(3.7)
Income tax provision	(3.4)	(3.3)
Net earnings (loss)	22.4	(0.4)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings (loss)	22.4	(0.4)
Other comprehensive income, net of tax	18.7	(12.1)
Total comprehensive income	41.1	(12.5)
Intercompany dividend	0	0
Guarantors
Income Statement [Abstract]
Net sales	296.1	299.7
Cost of products sold	189.3	192.8
Gross profit	106.8	106.9
Selling, general and administrative expense	59.1	51.2
Advertising and sales promotion expense	20.2	27.4
Research and development expense	13.8	12.6
Restructuring charges	3.1	8.9
Gain on sale of Infant and Pet Care business	(5.2)
Interest expense associated with debt	0.8	2.5
Other (income) expense, net	0.8	0.6
Intercompany service fees	(3.1)	(3.6)
Equity in earnings of subsidiaries	(21.2)	(11.5)
Earnings before income taxes	38.5	18.8
Income tax provision	6.2	9.1
Net earnings (loss)	32.3	9.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings (loss)	32.3	9.7
Other comprehensive income, net of tax	18.7	(12.1)
Total comprehensive income	51	(2.4)
Intercompany dividend	0	0
Non-Guarantors
Income Statement [Abstract]
Net sales	234.2	236.7
Cost of products sold	147.9	150.1
Gross profit	86.3	86.6
Selling, general and administrative expense	35.9	36.1
Advertising and sales promotion expense	20.9	24.2
Research and development expense	0	0
Restructuring charges	3	8.2
Gain on sale of Infant and Pet Care business	0
Interest expense associated with debt	0.2	0.1
Other (income) expense, net	(2.4)	0.7
Intercompany service fees	3.1	3.6
Equity in earnings of subsidiaries	0	0
Earnings before income taxes	25.6	13.7
Income tax provision	4.4	2.2
Net earnings (loss)	21.2	11.5
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings (loss)	21.2	11.5
Other comprehensive income, net of tax	19.7	(11.6)
Total comprehensive income	40.9	(0.1)
Intercompany dividend	$ (163.1)	$ (45)

Guarantor and Non-Guarantor F_4

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Dec. 31, 2019		Sep. 30, 2019		Dec. 31, 2018	Sep. 30, 2018
Current assets
Cash and cash equivalents	$ 251.8		$ 341.6		$ 239.9	$ 266.4
Trade receivables, net	183.2		205.6
Inventories	367		357.2
Other current assets	144.6		140
Total current assets	946.6		1,044.4
Investment in subsidiaries	0		0
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	384.8		396
Goodwill	1,030.8		1,032.8
Other intangible assets, net	843.7		912.9
Other assets	97.3		34.8
Total assets	3,303.2		3,420.9
Liabilities [Abstract]
Current liabilities	462.5		659.6
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	1,098.1		1,097.8
Deferred income tax liabilities	84		101.1
Other liabilities	310.5		258.9
Total liabilities	1,955.1		2,117.4
Shareholders’ equity
Total shareholders' equity	1,348.1		1,303.5		1,739.3	1,744.6
Total liabilities and shareholders' equity	3,303.2		3,420.9
Eliminations
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	(4,430.5)		(4,497)
Intercompany receivables, net	(959.4)	[1]	(936.9)	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	0		0
Total assets	(5,389.9)		(5,433.9)
Liabilities [Abstract]
Current liabilities	0		0
Intercompany payables, net	(959.4)	[1]	(936.9)	[2]
Long-term debt	0		0
Deferred income tax liabilities	0		0
Other liabilities	0		0
Total liabilities	(959.4)		(936.9)
Shareholders’ equity
Total shareholders' equity	(4,430.5)		(4,497)
Total liabilities and shareholders' equity	(5,389.9)		(5,433.9)
Parent
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	3,411.8		3,357.4
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	0.3		0.4
Total assets	3,412.1		3,357.8
Liabilities [Abstract]
Current liabilities	6.5		19.6
Intercompany payables, net	959.4	[1]	936.9	[2]
Long-term debt	1,098.1		1,097.8
Deferred income tax liabilities	0		0
Other liabilities	0		0
Total liabilities	2,064		2,054.3
Shareholders’ equity
Total shareholders' equity	1,348.1		1,303.5
Total liabilities and shareholders' equity	3,412.1		3,357.8
Guarantors
Current assets
Cash and cash equivalents	73		2.6		2.2	2.5
Trade receivables, net	44.1		43.7
Inventories	198.8		193.1
Other current assets	63.3		59.7
Total current assets	379.2		299.1
Investment in subsidiaries	1,018.7		1,139.6
Intercompany receivables, net	892.6	[1]	878.7	[2]
Property, plant and equipment, net	279.5		292.1
Goodwill	733		741
Other intangible assets, net	639.2		711.8
Other assets	28		0.2
Total assets	3,970.2		4,062.5
Liabilities [Abstract]
Current liabilities	256.9		409.7
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	0		0
Deferred income tax liabilities	71.7		88.7
Other liabilities	229.8		206.7
Total liabilities	558.4		705.1
Shareholders’ equity
Total shareholders' equity	3,411.8		3,357.4
Total liabilities and shareholders' equity	3,970.2		4,062.5
Non-Guarantors
Current assets
Cash and cash equivalents	178.8		339		$ 237.7	$ 263.9
Trade receivables, net	139.1		161.9
Inventories	168.2		164.1
Other current assets	81.3		80.3
Total current assets	567.4		745.3
Investment in subsidiaries	0		0
Intercompany receivables, net	66.8	[1]	58.2	[2]
Property, plant and equipment, net	105.3		103.9
Goodwill	297.8		291.8
Other intangible assets, net	204.5		201.1
Other assets	69		34.2
Total assets	1,310.8		1,434.5
Liabilities [Abstract]
Current liabilities	199.1		230.3
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	0		0
Deferred income tax liabilities	12.3		12.4
Other liabilities	80.7		52.2
Total liabilities	292.1		294.9
Shareholders’ equity
Total shareholders' equity	1,018.7		1,139.6
Total liabilities and shareholders' equity	$ 1,310.8		$ 1,434.5
[1]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.
[2]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.

Guarantor and Non-Guarantor F_5

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flow from Operating Activities
Net cash flow (used by) from operations	$ (46.9)	$ (46.4)
Cash Flow from Investing Activities
Capital expenditures	(7.6)	(9.4)
Proceeds from sale of Infant and Pet Care business	95.8	0
Collection of deferred purchase price from accounts receivable sold	2.8	2.5
Proceeds from sale of assets	0	4
Intercompany receivables (payables), net	0
Payments for other investing activities	(1.3)	0
Net cash from (used by) investing activities	89.7	(2.9)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	50	137
Cash payments on debt with original maturities greater than 90 days	(167)	(105)
Net decrease in debt with original maturities of 90 days or less	(0.1)	(0.9)
Interco receivables (payables), net	0
Net financing outflow from the Accounts Receivable Facility	(14.9)	(5.1)
Intercompany dividend	0	0
Employee shares withheld for taxes	(1.5)	(1.5)
Payments for other financing activities	(2.4)	0
Net cash from (used by) financing activities	(135.9)	24.5
Effect of exchange rate changes on cash	3.3	(1.7)
Net decrease in cash and cash equivalents	(89.8)	(26.5)
Cash and cash equivalents, beginning of period	341.6	266.4
Cash and cash equivalents, end of period	251.8	239.9
Eliminations
Cash Flow from Operating Activities
Net cash flow (used by) from operations	(163.1)	(45)
Cash Flow from Investing Activities
Capital expenditures	0	0
Proceeds from sale of Infant and Pet Care business	0
Collection of deferred purchase price from accounts receivable sold	0	0
Proceeds from sale of assets	0	0
Intercompany receivables (payables), net	22.5
Payments for other investing activities	0
Net cash from (used by) investing activities	22.5	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net decrease in debt with original maturities of 90 days or less	0	0
Interco receivables (payables), net	(22.5)
Net financing outflow from the Accounts Receivable Facility	0	0
Intercompany dividend	163.1	45
Employee shares withheld for taxes	0	0
Payments for other financing activities	0
Net cash from (used by) financing activities	140.6	45
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Parent
Cash Flow from Operating Activities
Net cash flow (used by) from operations	(21)	1.5
Cash Flow from Investing Activities
Capital expenditures	0	0
Proceeds from sale of Infant and Pet Care business	0
Collection of deferred purchase price from accounts receivable sold	0	0
Proceeds from sale of assets	0	0
Intercompany receivables (payables), net	0
Payments for other investing activities	0
Net cash from (used by) investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net decrease in debt with original maturities of 90 days or less	0	0
Interco receivables (payables), net	22.5
Net financing outflow from the Accounts Receivable Facility	0	0
Intercompany dividend	0	0
Employee shares withheld for taxes	(1.5)	(1.5)
Payments for other financing activities	0
Net cash from (used by) financing activities	21	(1.5)
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Cash Flow from Operating Activities
Net cash flow (used by) from operations	135.4	(24.6)
Cash Flow from Investing Activities
Capital expenditures	(4.7)	(6.5)
Proceeds from sale of Infant and Pet Care business	95.8
Collection of deferred purchase price from accounts receivable sold	2.8	2.5
Proceeds from sale of assets	0	4
Intercompany receivables (payables), net	(22.5)
Payments for other investing activities	0
Net cash from (used by) investing activities	71.4	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	50	137
Cash payments on debt with original maturities greater than 90 days	(167)	(105)
Net decrease in debt with original maturities of 90 days or less	(2.1)	(2.6)
Interco receivables (payables), net	0
Net financing outflow from the Accounts Receivable Facility	(14.9)	(5.1)
Intercompany dividend	0	0
Employee shares withheld for taxes	0	0
Payments for other financing activities	(2.4)
Net cash from (used by) financing activities	(136.4)	24.3
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	70.4	(0.3)
Cash and cash equivalents, beginning of period	2.6	2.5
Cash and cash equivalents, end of period	73	2.2
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow (used by) from operations	1.8	21.7
Cash Flow from Investing Activities
Capital expenditures	(2.9)	(2.9)
Proceeds from sale of Infant and Pet Care business	0
Collection of deferred purchase price from accounts receivable sold	0	0
Proceeds from sale of assets	0	0
Intercompany receivables (payables), net	0
Payments for other investing activities	(1.3)
Net cash from (used by) investing activities	(4.2)	(2.9)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net decrease in debt with original maturities of 90 days or less	2	1.7
Interco receivables (payables), net	0
Net financing outflow from the Accounts Receivable Facility	0	0
Intercompany dividend	(163.1)	(45)
Employee shares withheld for taxes	0	0
Payments for other financing activities	0
Net cash from (used by) financing activities	(161.1)	(43.3)
Effect of exchange rate changes on cash	3.3	(1.7)
Net decrease in cash and cash equivalents	(160.2)	(26.2)
Cash and cash equivalents, beginning of period	339	263.9
Cash and cash equivalents, end of period	$ 178.8	$ 237.7

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions		May 09, 2019	Dec. 31, 2019	Dec. 31, 2018
Subsequent Event [Line Items]
Acquisition and planning costs	[1]		$ 6.2	$ 0.5
Selling, general and administrative expenses
Subsequent Event [Line Items]
Acquisition and planning costs			$ 6.2
Harry's
Subsequent Event [Line Items]
Business combination, purchase price		$ 1,370
[1]	Includes pre-tax SG&A of $6.2 and $0.5 for the three months ended December 31, 2019 and 2018, respectively, related to acquisition and integration planning costs.